دانلود مقالات ISI درباره مدت زمان پاسخ + ترجمه فارسی

ایمونوتراپی با استفاده از مانیتور بازرسی در درمان سرطان پروستات

Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma

Keywords: مدت زمان پاسخ; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4

دانلود رایگان متن کامل مقاله ISI 14 صفحه سال انتشار : 2018 سفارش ترجمه

اثربخشی و ایمنی ایربولین به عنوان اولین درمان در بیماران مبتلا به سرطان پستان پیشرفته یا متاستاتیک که قبلا توسط آنتراسیکلین و مالیون درمان شده بود

Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes

Keywords: مدت زمان پاسخ; Eribulin; Metastatic breast cancer; First-line; Microtubule; Dose-intensity; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; DCR; disease control rate; DOR; duration of response; ECOG PS; Eas

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2017 سفارش ترجمه

قدرت اعتبار سنجی برای نمرات نقطه پایانی مورد استفاده در تایید مواد مخدر و داروهای انکولوژیک اداره غذا و دارو ایالات متحده

Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs

Keywords: مدت زمان پاسخ; AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl

دانلود رایگان متن کامل مقاله ISI 13 صفحه سال انتشار : 2016 سفارش ترجمه

Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives

Keywords: مدت زمان پاسخ; NNSCLC; non-small cell lung cancer; OS; overall survival; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; ALK; Anaplastic lymphoma kinase; MET; mesenchymal epithelial transition factor; PFS; progression free survival; HER2; human e

دانلود رایگان متن کامل مقاله ISI 13 صفحه سال انتشار : 2018 سفارش ترجمه

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer

Keywords: مدت زمان پاسخ; BID; twice daily; CARBO-ETOP; carboplatin-etoposide therapy; CDK; cyclin-dependent kinase; CI; confidence interval; CIS-ETOP; cisplatin-etoposide therapy; DCR; disease control rate; DLT; dose-limiting toxicity; DoR; duration of response; ED-SCLC; extensiv

دانلود رایگان متن کامل مقاله ISI 36 صفحه سال انتشار : 2018 سفارش ترجمه

Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic

Keywords: مدت زمان پاسخ; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2′-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;

دانلود رایگان متن کامل مقاله ISI 78 صفحه سال انتشار : 2018 سفارش ترجمه

Mini-reviewPD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges

Keywords: مدت زمان پاسخ; PD1; PD-L1; NSCLC; Efficacy; Challenges; PD-1; programmed death-1; PD-L1; programmed death ligand-1; NSCLC; Non-small cell lung cancer; ORR; overall response rate; DOR; duration of response; OS; overall survival; PFS; progression free survival; AE; advers

دانلود رایگان متن کامل مقاله ISI 9 صفحه سال انتشار : 2017 سفارش ترجمه

Original ResearchENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

Keywords: مدت زمان پاسخ; ENGOT-ov-6/TRINOVA-2; Trebananib; Pegylated liposomal doxorubicin; Progression-free survival; Objective response rate; Duration of response;

دانلود رایگان متن کامل مقاله ISI 11 صفحه سال انتشار : 2017 سفارش ترجمه

Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer

Keywords: مدت زمان پاسخ; AE; Adverse Event; α-MSH; alpha-Melanocyte Stimulating Hormone; ADC; Antibody-Drug Conjugate; ASPS; Alveolar Soft Part Sarcoma; ASPSCR1; Alveolar Soft Part Sarcoma Chromosome Region Candidate 1; BMP-2; Bone Morphogenetic Protein-2; BRK; Breast Tumor Kina

دانلود رایگان متن کامل مقاله ISI 15 صفحه سال انتشار : 2017 سفارش ترجمه

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC

Keywords: مدت زمان پاسخ; advanced basal cell carcinoma; ERIVANCE BCC study; Hedgehog pathway inhibitor; locally advanced basal cell carcinoma; metastatic basal cell carcinoma; vismodegib; AE; adverse event; BCC; basal cell carcinoma; CI; confidence interval; DOR; duration of resp

دانلود رایگان متن کامل مقاله ISI 14 صفحه سال انتشار : 2015 سفارش ترجمه

The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis

Keywords: مدت زمان پاسخ; alefacept; duration of response; open-label extension study; remissionC/AC, clear or almost clear; CI, confidence interval; Emax, maximum reduction of lymphocytes; IM, intramuscular; LLN, lower limit of normal; MOB, mild or better; PASI, Psoriasis Area an

دانلود رایگان متن کامل مقاله ISI 11 صفحه سال انتشار : 2010 سفارش ترجمه

A Phase II Pilot Study to Evaluate Use of Intravenous Lidocaine for Opioid-Refractory Pain in Cancer Patients

Keywords: مدت زمان پاسخ; Intravenous; lidocaine; cancer pain; opioid refractory; side effect; durability of response; duration of response; single infusion

دانلود رایگان متن کامل مقاله ISI 9 صفحه سال انتشار : 2009 سفارش ترجمه

Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses

Keywords: مدت زمان پاسخ; topical corticosteroids; potency; vehicle; vasoconstriction; anti-inflammatory; clobetasol propionate; Class I agents; plaque-type psoriasis; atopic dermatitis; efficacy; safety; duration of response; cosmetic acceptability;

دانلود رایگان متن کامل مقاله ISI 18 صفحه سال انتشار : 2005 سفارش ترجمه